Retrospective Analysis of Serum Parameters in Patients Treated With Check-Point Inhibitors in 2AND Line for Advance Non-small-Cell Lung Cancer

被引：0
|
作者：
Paco, Pablo Flores [1 ,2 ]
Moreno, Alberto [1 ,2 ]
Barneto, Isidoro [1 ,2 ]
Sanchez, Pedro [1 ,2 ]
Vargas, Alicia [1 ,2 ]
Guevara, Geraldina [1 ,2 ]
Lopez-Herrero, Maria [1 ,2 ]
Aranda, Enrique [1 ,2 ]
机构：
[1] Univ Reina Sofia, Cordoba, Spain
[2] Inst Maimonides Invest Biomed Cordoba, Cordoba, Spain
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PP.43
引用
收藏
页码：S25 / S26
页数：2
相关论文
共 50 条
  • [1] Venous thromboembolism in patients with advanced non-small cell lung cancer treated with immune check-point inhibitors: a retrospective cohort study
    Icht, O.
    Darzi, N.
    Landman, Y.
    Reinhorn, D.
    Shochat, T.
    Jacobi, O.
    Rotem, O.
    Dudnik, E.
    Spectre, G.
    Raanani, P.
    Zer, A.
    Leader, A.
    THROMBOSIS RESEARCH, 2021, 200 : S49 - S50
  • [2] Natural killer cell activity as a prognostic biomarker in non-small cell lung cancer patients treated with check-point inhibitors
    Wen, S. W. C.
    Hansen, T. S.
    Nederby, L.
    Andersen, R. F.
    Nyhus, C. H.
    Bertelsen, L.
    Sorensen, B. T.
    Hager, H.
    Hilberg, O.
    Jakobsen, A.
    Hansen, T. F.
    ANNALS OF ONCOLOGY, 2020, 31 : S853 - S853
  • [3] Electrolyte disorders in advanced non-small cell lung cancer patients treated with immune check-point inhibitors: A systematic review and meta-analysis
    Cantini, Luca
    Merloni, Filippo
    Rinaldi, Silvia
    Lenci, Edoardo
    Marcantognini, Giulia
    Meletani, Tania
    Fiordoliva, Ilaria
    Morgese, Francesca
    Torniai, Mariangela
    Ricci, Giulia
    Giampieri, Riccardo
    Berardi, Rossana
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2020, 151
  • [4] Bevacizumab for stereotactic radiosurgery-induced radiation necrosis in patients with non-small cell lung cancer treated with immune check-point inhibitors
    Moore, Assaf
    Yust-Katz, Shlomit
    Icht, Oded
    Eliyahou, Ruth
    Gordon, Noa
    Cohen, Aharon Yehonatan
    Goldstein, Iris Magdalena
    Peled, Nir
    Seigal, Tali
    Amiel, Alexandra
    Dudnik, Elizabeth
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 427
  • [5] Releasing the brake: safety profile of immune check-point inhibitors in non-small cell lung cancer
    Genova, Carlo
    Rossi, Giovanni
    Rijavec, Erika
    Biello, Federica
    Barletta, Giulia
    Tagliamento, Marco
    Grossi, Francesco
    EXPERT OPINION ON DRUG SAFETY, 2017, 16 (05) : 573 - 585
  • [6] Retrospective analysis of a group of patients with advanced Non-Small-Cell lung cancer (NSCLC) treated with Gefitinib
    Bandera, M.
    Bascialla, L.
    Martinelli, B.
    Masera, G. L. Rodolfo
    Vallini, I.
    Zanlorenzi, L.
    Pinotti, G.
    ANNALS OF ONCOLOGY, 2005, 16 : 25 - 25
  • [7] Comparison between PERCIST and EORTC criteria in the evaluation of response to immune check-point inhibitors in Non-Small Cell Lung Cancer (NSCLC) patients
    Piva, R.
    Rossi, G.
    Bauckneht, M.
    Genova, C.
    Ceriani, V.
    Rijavec, E.
    Barletta, G.
    Biello, F.
    Calamia, I.
    Dal Bello, G.
    Di Stefano, R.
    Sambuceti, G.
    Grossi, F.
    Morbelli, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S674 - S674
  • [8] The rate of venous thromboembolism in patients with non-small cell lung cancer treated with chemotherapy or check point inhibitors.
    Singu, Sriharsha
    Bakalov, Veli
    Helfand, Alexander M.
    Kancharla, Pragnan
    White, Richard
    Khattab, Ahmed
    Miller, Katherine
    Samhouri, Yazan
    Finley, Gene Grant
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [9] Rare targetable drivers (RTDs) in non-small cell lung cancer (NSCLC): Outcomes with immune check-point inhibitors (ICPi)
    Dudnik, Elizabeth
    Bshara, Elias
    Grubstein, Ahuva
    Fridel, Ludmila
    Shochat, Tzippy
    Roisman, Laila C.
    Ilouze, Maya
    Rozenblum, Anna Belilovski
    Geva, Smadar
    Zer, Alona
    Rotem, Ofer
    Allen, Aaron M.
    Peled, Nir
    LUNG CANCER, 2018, 124 : 117 - 124
  • [10] A retrospective analysis of cisplatin, pemetrexed, and bevacizumab in previously treated non-small-cell lung cancer
    Liu, Ke-Jun
    Wu, Hai-Ying
    ONCOTARGET, 2015, 6 (26) : 22750 - 22757
12345